In The News Posted March 17, 2021 Share Posted March 17, 2021 TAMPA, Fla. and NEW YORK, March 17, 2021 /PRNewswire/ -- M2GEN today announced a significant new investment by Clayton, Dubilier & Rice ("CD&R") funds, the Merck Global Health Innovation Fund ("Merck GHI"), and McKesson Ventures to recapitalize M2GEN, a leading oncology data and...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.